Skip to main content

Nasdaq Stocks

Merck (MRK) Stock Moves -0.37%: What You Should Know

6 years 1 month ago
Merck (MRK) closed the most recent trading day at $82.63, moving -0.37% from the previous trading session. This move was narrower than the S&P 500's daily loss of 2.37%. Elsewhere, the Dow lost 1.92%, while the tech-heavy Nasdaq lost 3.02%.

Coronavirus Continues to Hurt Airlines : Any Respite Soon?

6 years 1 month ago
It is a well-documented fact that stocks in the airline space could not set the stage on fire in 2019 due to headwinds like lackluster cargo business and loss of revenues following flight cancellations stemming from the grounding of Boeing 737 MAX jets. These drawbacks continued

UHS or THC: Which is a Better-Positioned Stock Right Now?

6 years 1 month ago
The Zacks Medical - Hospital industry faced disruption due to the COVID-19-led pandemic. However, they are slowly limping back to normalcy by resuming surgeries and other healthcare services.The hospital industry suffered heavily due to the COVID-19-induced business loss. Cancel

Blueprint Medicines Up on Positive Top-Line Data From SM Study

6 years 1 month ago
Shares of Blueprint Medicines Corporation BPMC were up 13% on Tuesday after the company announced positive top-line data from the phase I EXPLORER study and the phase II PATHFINDER study, which evaluated its lead drug Ayvakit (avapritinib) for the treatment of patients with adva

RedHill Gets Nod in Brazil for Coronavirus Study on Opaganib

6 years 1 month ago
RedHill Biopharma Ltd. RDHL announced that the Brazilian Health Regulatory Agency (ANVISA) has approved the ongoing phase II/III study on its novel investigational candidate opaganib, also called Yeliva. The company is looking to evaluate opaganib in patients hospitalized with s
Checked
1 minute 35 seconds ago
This feed is responsible for generating the rss feed related to the topic Stocks
Subscribe to Nasdaq Stocks feed